Please try another search
Hainan Shuangcheng Pharmaceuticals Co., Ltd. is a China-based company principally engaged in the production, sale, research and development of chemically synthesized peptide drugs. The Company's main products include Jitai (thymalfasin for injection), for the treatment of various types of liver diseases, cancers, geriatric deseases and infectious diseases; thymopentin for infection; somatostatin, for the treatment of severe acute esophageal variceal bleeding and severe acute stomach or for the adjuvant therapy of duodenal ulcer bleeding and diabetic ketoacidosis, as well as other drugs. The Company distributes its products in domestic market and to overseas markets.
Name | Age | Since | Title |
---|---|---|---|
Chengdong Wang | - | 2000 | Chairman |
Yingpu Wang | - | - | Vice Chairman |
Jianming Li | - | 2020 | GM & Non-Independent Director |
Jing Bai | 40 | 2022 | Vice Chairman |
Bin Fu | 47 | 2010 | Non-Employee Supervisor |
Hongyu Wang | 53 | 2017 | Chairman of the Supervisory Board |
Jianhua Xiao | - | 2023 | Independent Director |
Jianwei Li | - | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review